Scientists at The Australian National University have developed an innovative “trojan horse” drug delivery method that exploits malaria parasites’ dependence on cholesterol, a vital molecule they cannot produce themselves. By attaching cholesterol to drugs, the parasites actively ingest these disguised treatments, allowing the drugs to reach and kill them more effectively—3 to 25 times better than conventional methods. This approach not only enhances the efficacy of existing malaria drugs but also revives those that have lost potency due to resistance, potentially leading to cheaper and longer-lasting therapies.

Beyond malaria, this cholesterol-based delivery system shows promise for treating other parasitic diseases such as giardia and leishmaniasis, which affect humans and animals alike. The technique could also benefit the agricultural sector by protecting livestock from parasitic infections that cause significant economic losses. Overall, this breakthrough offers a versatile platform for developing more efficient treatments against a range of deadly parasites impacting global health and agriculture.